Any feedback?
Literature summary for 1.3.8.8 extracted from
- Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine (2008), Pediatr. Res., 63, 632-637.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | VLCAD deficiency is characterized by elevated tissue levels of C14-C18 acyl-carnitines | Mus musculus |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Mus musculus | - |
- |
- |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| acyl-CoA + acceptor | - |
Mus musculus | 2,3-dehydroacyl-CoA + reduced acceptor | - |
? |  |
| palmitoyl-CoA + electron-transfer flavoprotein | - |
Mus musculus | (2E)-2-hexadecenoyl-CoA + reduced electron-transfer flavoprotein | - |
? | |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| very long-chain acyl-CoA dehydrogenase | metabolizes C14-C18 acyl-carnitines | Mus musculus |
| VLCAD | - |
Mus musculus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
